D-myo-Inositol-1,3,4-triphosphate sodium salt is one of many inositol oligophosphate isomers implicated in signal transduction. Ins(1,3,4)-P3 acts through the inhibition of Ins(3,4,5,6)-P4 kinase activity to increase the cellular level of Ins(3,4,5,6)-P4 and thus inhibit calcium-activated chloride channels. The levels of Ins(1,3,4)-P3 are regulated by the levels of cytosolic free calcium. The receptor-mediated activation of phospholipase C (PLC) can be seen as the initiating event in this cascade, since PLC generates Ins(1,4,5)-P3 which releases calcium from intracellular storage reservoirs. This leads to increase in the cytosolic concentration of free calcium.
1. Majerus, P.W. 1992. Annu. Rev. Biochem. 61: 225-250. PMID: 1323235
2. Berridge, M.J. 1993. Nature. 361: 315-325. PMID: 8381210
3 Yang, X., et al. 1999. J Biol Chem 274: 18973-18980.PMID: 10383396
4 Lew, P.D., et al. 1986. J Biol Chem. 261: 13121-13127. PMID: 3489712 5 Yoshida, Y. and Imai, S. 1997. Jpn. J. Pharmacol. 74: 125-137. PMID: 9243320
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.